Accessibility settings

This paper is in the following e-collection/theme issue:

News and Perspectives (130)

Published on in Vol 28 (2026)

Person using a smartphone to monitor a continuous glucose monitor (CGM) on their arm.

The US Food and Drug Administration’s TEMPO Pilot Signals a New Regulatory Approach for AI-Enabled Medical Devices

The US Food and Drug Administration’s TEMPO Pilot Signals a New Regulatory Approach for AI-Enabled Medical Devices

Authors of this article:

Tejas S Athni, JMIR Correspondent
Article Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref .